Hypercalcemia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Hypercalcemia Treatment Market Overview, Industry Top Manufactures, Market Size, Industry Growth Analysis ... - Facts of Week



Hypercalcemia Treatment Market Overview, Industry Top Manufactures, Market Size, Industry Growth Analysis ... 
Facts of Week
Hypercalcemia Treatment Market Report Deliver an in-depth assessment of the Hypercalcemia Treatment including qualifying Technologies, Key trends, Market drivers, Challenges, Standardization, regulatory landscape, deployment models, opportunities ...

and more » 


Global Hypercalcemia Treatment Market 2021 Technological Innovation, Type, Applications, Market Dynamics - The Financial



Global Hypercalcemia Treatment Market 2021 Technological Innovation, Type, Applications, Market Dynamics 
The Financial
The ?Hypercalcemia Treatment Market? report gives an intelligible understanding of the present market condition which includes of substantial and predictable upcoming keyword opportunities for the investors and new entrants. This Report provides key ...

 


KDIGO Releases CKD-MBD Guidelines, Targets PCPs, Nephrologists - Medscape



Medscape
 
KDIGO Releases CKD-MBD Guidelines, Targets PCPs, Nephrologists 
Medscape
Now, the work group recommends that only patients with hyperphosphatemia be treated and that hypercalcemia be avoided in patients with CKD G3a to G5D. The authors also suggest that prevention, as opposed to treatment of hyperphosphatemia, may be ...

 


CKD-MBD Guideline Synopsis Issued - Renal and Urology News



Renal and Urology News
 
CKD-MBD Guideline Synopsis Issued 
Renal and Urology News
Trends in laboratory values of serum phosphate, calcium, and parathyroid hormone, taken together, should guide treatment decisions, rather than single abnormalities, according to the new recommendations. Clinicians should treat only overt ...

 


Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease?Mineral and Bone Disorder: Synopsis of ... - Annals of Internal Medicine



Infosurhoy
 
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease?Mineral and Bone Disorder: Synopsis of ... 
Annals of Internal Medicine
This synopsis focuses primarily on recommendations for diagnosis of and testing for CKD?MBD and treatment of CKD?MBD that emphasizes decreasing phosphate levels, maintaining calcium levels, and addressing elevated parathyroid hormone levels in adults ...
Guidelines call for decreasing phosphate, maintaining calcium levels in patients with CKD?MBD Healio

all 5 news articles » 


Study identifies racial disparities in multiple myeloma treatment, outcomes - Healio



Study identifies racial disparities in multiple myeloma treatment, outcomes 
Healio
Factors such as hypercalcemia, bone fractures and renal dysfunction appeared linked with an inferior OS. Although black and Asian patients demonstrated a superior OS to white patients overall, racial disparities in OS shrank between 2006 and 2010 ...

 


XOMA Corporation (XOMA) Analysts See $-0.51 EPS - Frisco Fastball - Frisco Fastball



Frisco Fastball
 
XOMA Corporation (XOMA) Analysts See $-0.51 EPS - Frisco Fastball 
Frisco Fastball
Analysts expect XOMA Corporation (NASDAQ:XOMA) to report $-0.51 EPS on March, 15.They anticipate $2.38 EPS change or 82.35 % from last quarter's $-2.89 EPS. After having $1.98 EPS previously, XOMA Corporation's analysts see -125.76 % EPS growth. The ...

and more » 


Hypercalcemia Treatment Market 2021 Revenue, Consumptions ... - MilTech



Hypercalcemia Treatment Market 2021 Revenue, Consumptions ... 
MilTech
Hypercalcemia Treatment Market report offers a whole analysis of Hypercalcemia Treatment so that its competitors are free to focus on their core business and help them to make good strategies. Development factors of market give the progressive data of ...

and more » 


+11.5% CAGR of Worldwide Hypercalcemia Treatment Market Top Players AbbVie, Amgen, Merck, Novartis, and ... - MilTech



+11.5% CAGR of Worldwide Hypercalcemia Treatment Market Top Players AbbVie, Amgen, Merck, Novartis, and ... 
MilTech
Global Hypercalcemia Treatment Market accounted to USD 76.9 billion in 2016 growing at a CAGR of 11.5% during the forecast period of 2017 to 2024. This report consists of below pages: No of pages: 350; No of Figures: 60; No of Tables: 220. Get Free ...

and more » 


Hypercalcemia Treatment Market Value to Reach US$ 25,230.2 Mn ... - MilTech



Hypercalcemia Treatment Market Value to Reach US$ 25,230.2 Mn ... 
MilTech
Global hypercalcemia treatment market revenues are anticipated to reach US$ 9.64 Bn in 2017, up from US$ 7.86 Bn in 2015. Increasing prevalence of hyperparathyroidism-related hypercalcemia and rising incidence of multiple myeloma are major factors ...

and more »